Type 2 Diabetes Connect
  • Saved
Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials - PubMed

Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35280867/

doi: 10.3389/fmed.2022.793203. 1 Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. 2 Key Laboratory of Chinese Internal Medicine of Ministry of Education...



Conclusion: The network meta-analysis provided evidence for the efficacy of vitamin E, pioglitazone, SGLT2 inhibitors, and GLP-1 receptor agonists in treating patients with NAFLD. To find the best guide-level drugs, it is necessary to include more RCTs with these off-label drugs, so that patients and clinicians can make optimal decisions...

  • Saved
Secular trends in global burden of diabetes attributable to particulate matter pollution from 1990 to 2019 - Environmental Science and Pollution Research

Secular trends in global burden of diabetes attributable to particulate matter pollution from 1990 to 2019 - Environmental Science and Pollution Research

Source : https://link.springer.com/article/10.1007/s11356-022-19510-6

Increasing evidence suggests an association between fine particulate matter (PM2.5) exposure and type 2 diabetes mellitus. However, there is still a lack of comparative evaluation regarding diabetes burden due to...



Conclusion/Relevance: The elderly and people in low-SDI countries suffered from the greatest burden of diabetes due to PM2.5 pollution. More targeted interventions should be taken by governments to reduce PM2.5 exposure and related diabetes burden.

  • Saved
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS) - PubMed

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS) - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35258841/

doi: 10.1007/s13300-022-01226-y. Online ahead of print. 1 Clinical Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia. [email protected]. 2 Medical Faculty, University of...



Discussion: This is the first study to investigate the direct and indirect anti-atherosclerotic mechanisms of oral semaglutide. The results are expected to confirm the position of oral semaglutide in the multifactorial management of T2D with an emphasis on cardiovascular disease prevention.

  • Saved
Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice

Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice

Source : https://www.clinicaltherapeutics.com/article/S0149-2918(22)00052-2/fulltext

Greater medication adherence and persistence have been associated with improved glycemic control in patients with type 2 diabetes mellitus. This study compared adherence, persistence, and treatment patterns among patients naïve...



Implications: At both 6M and 12M follow-up, dulaglutide initiators had significantly greater adherence and greater persistence compared with matched semaglutide initiators.

  • Saved
Adverse drug reactions of GLP-1 agonists: A systematic review of case reports

Adverse drug reactions of GLP-1 agonists: A systematic review of case reports

Source : https://www.sciencedirect.com/science/article/abs/pii/S1871402122000418?via=ihub

GLP-1 receptor agonists are most commonly associated with gastrointestinal problems, particularly pancreatitis. * Exenatide and liraglutide caused maximum ADRs, whereas albiglutide and lixisenatide caused minimum ADRs. * Renal, dermatologic, hematologic,...



Conclusion: Gastrointestinal problems, particularly pancreatitis was the more frequently reported adverse drug reaction associated with GLP-1 agonist. The most adverse drug reactions were observed with liraglutide and exenatide.